KLØ – Vial Bundle

The KLØ Bundle brings together four synthetic peptide sequences with distinct but complementary research profiles commonly studied within overlapping tissue repair, extracellular matrix, and inflammatory signaling research frameworks. Each vial is individually prepared and lyophilized, allowing researchers to deploy compounds independently or in combination according to their specific study design.

BPC-157 (10mg) is a synthetic pentadecapeptide studied in relation to growth factor receptor signaling, angiogenic pathway activity, and gastrointestinal tissue interface research in non-human models. TB-500 (10mg) is a synthetic Thymosin Beta-4 analogue studied in relation to actin-binding dynamics, cytoskeletal organization, and extracellular matrix signaling behavior. GHK-Cu (50mg) is a copper-binding tripeptide studied in relation to collagen synthesis signaling, metalloproteinase regulation, and gene expression modulation within tissue remodeling research. KPV (10mg) is a synthetic tripeptide fragment derived from alpha-MSH research, studied in relation to inflammatory signaling pathway modulation and epithelial barrier interface research in non-human models.

Research applications commonly explored in the literature include:

Angiogenic signaling and growth factor receptor pathway investigation in non-human tissue interface models

Actin-binding dynamics, cytoskeletal organization, and extracellular matrix signaling research

Copper peptide signaling, metalloproteinase regulation, and collagen synthesis pathway activity

Inflammatory signaling pathway modulation and epithelial barrier interface research

Multi-peptide combinatorial signaling investigation across complementary tissue remodeling and regenerative biology pathways

Comparative individual versus combined compound activity analysis in non-human tissue repair and epithelial signaling models

Each vial in the KLØ Bundle is individually prepared and filled in the United States under sterile laboratory conditions. All batches are verified by independent third-party laboratories for purity, volume accuracy, and molecular identity prior to release.

1. What compounds are included in the KLØ Bundle and what are they individually studied for?
The KLØ Bundle contains four individually lyophilized vials. BPC-157 is studied in relation to angiogenic signaling and growth factor receptor pathway activity. TB-500 is studied in relation to actin-binding dynamics and extracellular matrix signaling. GHK-Cu is studied in relation to collagen synthesis signaling, metalloproteinase regulation, and gene expression modulation in tissue remodeling research. KPV is studied in relation to inflammatory signaling pathway modulation and epithelial barrier interface research. Scientific literature examines all four compounds within overlapping tissue interface, regenerative biology, and inflammatory signaling research frameworks.

2. How does the KLØ Bundle differ from the KLØ Blend 80mg?
The KLØ Bundle contains four individually lyophilized vials, allowing researchers to handle, reconstitute, and deploy each compound separately according to their study protocol. The KLØ Blend 80mg contains the same four peptide sequences co-lyophilized within a single vial. The bundle format supports research designs requiring independent compound preparation or variable dosing parameters across individual peptide sequences.

3. Can the compounds in the KLØ Bundle be studied individually or must they be used together?
Each vial is individually prepared and can be studied independently or in combination depending on the research protocol. The bundle format is designed to support flexible study designs, including single-compound, multi-compound, and comparative research models.

4. Why are these four compounds commonly studied together in research literature?
Scientific literature examines BPC-157, TB-500, GHK-Cu, and KPV together due to their complementary and non-overlapping signaling mechanisms across tissue interface research — angiogenic growth factor signaling, actin-mediated cytoskeletal dynamics, copper peptide gene expression regulation, and inflammatory pathway modulation each engage distinct pathway nodes. Multi-peptide study designs allow researchers to investigate whether concurrent engagement of these pathways produces differentiated signaling outcomes compared to individual compound models.

5. How is purity and quality verified across all four vials?
Each vial in the KLØ Bundle undergoes independent third-party laboratory testing individually to confirm molecular identity, purity, and volume accuracy prior to release. Certificates of Analysis are available for each compound within the bundle.

Before Reconstitution

Store sealed vials in a freezer at -20°C (–4°F)

Keep away from light and humidity

After Reconstitution

Store at 4°C (39°F)

Use within 14 days

Avoid repeated freeze-thaw cycles

Each compound in this bundle is supplied as a lyophilized powder.
Use KÖLD Solution (sterile, lab-grade solvent) if your protocol requires reconstitution.
Reconstitute individual vials only when ready to begin your study.
For research use only. Not for human or animal use.
Not intended to diagnose, treat, cure, or prevent any disease.